Identification of a family of peptidoglycan transpeptidases reveals that <i>Clostridioides difficile</i> requires noncanonical cross-links for viability
Most bacteria are surrounded by a cell wall that contains peptidoglycan (PG), a large polymer composed of glycan strands held together by short peptide cross-links. There are two major types of cross-links, termed 4-3 and 3-3 based on the amino acids involved. 4-3 cross-links are created by penicillin-binding proteins, while 3-3 cross-links are created by L,D-transpeptidases (LDTs). In most bacteria, the predominant mode of cross-linking is 4-3, and these cross-links are essential for viability, while 3-3 cross-links comprise only a minor fraction and are not essential. However, in the opportunistic intestinal pathogen <i>Clostridioides difficile,</i> about 70% of the cross-links are 3-3. We show here that 3-3 cross-links and LDTs are essential for viability in <i>C. difficile</i>. We also show that <i>C. difficile</i> has five LDTs, three with a YkuD catalytic domain as in all previously known LDTs and two with a VanW catalytic domain, whose function was until now unknown. The five LDTs exhibit extensive functional redundancy. VanW domain proteins are found in many gram-positive bacteria but scarce in other lineages. We tested seven non-<i>C. difficile</i> VanW domain proteins and confirmed LDT activity in three cases. In summary, our findings uncover a previously unrecognized family of PG cross-linking enzymes, assign a catalytic function to VanW domains, and demonstrate that 3-3 cross-linking is essential for viability in <i>C. difficile</i>, the first time this has been shown in any bacterial species. The essentiality of LDTs in <i>C. difficile</i> makes them potential targets for antibiotics that kill <i>C. difficile</i> selectively.
Authors
- Kevin W. Bollinger (ORCID: https://orcid.org/0000-0002-7694-2200)
- Richard F. Helm (ORCID: https://orcid.org/0000-0001-5317-0925)
- David S. Weiss (ORCID: https://orcid.org/0000-0003-2217-0070)
- Marcos M. Pires (ORCID: https://orcid.org/0000-0002-5676-0725)
- Karl L. Ocius (ORCID: https://orcid.org/0009-0008-0578-8964)
- David L. Popham (ORCID: https://orcid.org/0000-0002-2614-143X)
- Ute Müh (ORCID: https://orcid.org/0009-0007-7114-019X)
- Craig D. Ellermeier (ORCID: https://orcid.org/0000-0002-8953-5081)
- Alexis J. Apostolos
Institutions
- University of Iowa (US)
- University of Virginia (US)
- Virginia Tech (US)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1073/pnas.2408540121
- Citations
- 15
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 5.84
Funders
- National Science Foundation
- National Institute of General Medical Sciences
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases